Colgate-Palmolive (NYSE:CL) Price Target Increased to $95.00 by Analysts at Royal Bank of Canada

Colgate-Palmolive (NYSE:CL) had its target price raised by Royal Bank of Canada from $88.00 to $95.00 in a report published on Monday morning, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the stock.

Several other equities research analysts have also recently commented on CL. TheStreet raised Colgate-Palmolive from a c+ rating to a b+ rating in a research report on Friday, January 26th. Barclays increased their price objective on Colgate-Palmolive from $82.00 to $84.00 and gave the company an equal weight rating in a research report on Friday, April 12th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a buy rating and a $93.00 price objective on the stock. Raymond James raised Colgate-Palmolive from a market perform rating to an outperform rating and set a $91.00 price objective on the stock in a research report on Monday, January 29th. Finally, Morgan Stanley increased their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the company an overweight rating in a research report on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of Moderate Buy and an average price target of $91.38.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $90.49 on Monday. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $92.25. The company has a debt-to-equity ratio of 8.59, a current ratio of 0.42 and a quick ratio of 0.28. The business has a fifty day moving average price of $87.80 and a 200-day moving average price of $81.77. The company has a market capitalization of $74.38 billion, a PE ratio of 28.64, a PEG ratio of 3.42 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the company earned $0.73 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. As a group, equities analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.21%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the transaction, the insider now owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the transaction, the executive vice president now directly owns 8,043 shares in the company, valued at approximately $686,470.05. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 over the last quarter. 0.37% of the stock is currently owned by company insiders.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. OFI Invest Asset Management bought a new stake in Colgate-Palmolive during the 3rd quarter valued at approximately $25,000. Union Savings Bank raised its stake in Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. Avion Wealth increased its stake in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the last quarter. Atlantic Edge Private Wealth Management LLC bought a new stake in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Finally, PSI Advisors LLC increased its stake in Colgate-Palmolive by 4,971.4% in the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after acquiring an additional 348 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.